Galderma Financial Statements From 2010 to 2026

Stocks . Switzerland . 
Stock . Galderma Group N
GALD Stock   154.20  0.40  0.26%   
Galderma Group's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Galderma Group's valuation are provided below:
Gross Profit
3.2 B
Profit Margin
0.0806
Market Capitalization
36.6 B
Enterprise Value Revenue
9.3026
Revenue
4.7 B
There are over one hundred nineteen available fundamental trends for Galderma Group N, which can be analyzed over time and compared to other ratios. All traders should should confirm Galderma Group's regular fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.

Galderma Group Total Revenue

4.08 Billion

Check Galderma Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Galderma Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.5 M, Interest Expense of 418 M or Selling General Administrative of 495.8 M, as well as many indicators such as Price To Sales Ratio of 3.27, Dividend Yield of 0.0 or PTB Ratio of 3.29. Galderma financial statements analysis is a perfect complement when working with Galderma Group Valuation or Volatility modules.
  
This module can also supplement various Galderma Group Technical models . Check out the analysis of Galderma Group Correlation against competitors.

Galderma Group Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.7 B14.5 B11.7 B
Slightly volatile
Short and Long Term Debt Total3.5 B2.5 B4.7 B
Slightly volatile
Other Current Liabilities854.1 M939.5 M787.8 M
Slightly volatile
Total Current Liabilities1.3 B1.4 B1.6 B
Slightly volatile
Total Stockholder Equity5.7 B9 B4.8 B
Slightly volatile
Property Plant And Equipment Net469.1 M664.7 M368.5 M
Slightly volatile
Current Deferred Revenue840.1 K1.3 M558.4 K
Slightly volatile
Net Debt3.2 B2.1 B4.4 B
Slightly volatile
Accounts Payable565 M656.6 M489.2 M
Slightly volatile
Cash341.5 M525.5 M291.8 M
Slightly volatile
Non Current Assets Total11 B12.4 B10.3 B
Slightly volatile
Cash And Short Term Investments342.3 M525.5 M293.6 M
Slightly volatile
Net Receivables780.8 M1 B705.8 M
Slightly volatile
Good Will5.2 B5.9 B4.8 B
Slightly volatile
Common Stock Shares Outstanding261.3 M273.3 M241.1 M
Slightly volatile
Short Term Investments191.5 M182.4 M39.4 M
Slightly volatile
Liabilities And Stockholders Equity12.7 B14.5 B11.7 B
Slightly volatile
Non Current Liabilities Total3.8 B3 B5.2 B
Slightly volatile
Inventory407.3 M463.4 M342.8 M
Slightly volatile
Other Current Assets82.8 M65.7 M122.6 M
Slightly volatile
Other Stockholder Equity3.4 B1.9 B4.4 B
Slightly volatile
Total Liabilities5.1 B4.3 B6.8 B
Slightly volatile
Total Current Assets1.6 B2.1 B1.5 B
Slightly volatile
Short Term Debt30.8 M32.4 M306.6 M
Slightly volatile
Intangible Assets3.7 B4.3 B4.7 B
Slightly volatile
Common Stock3.7 M2.7 M4.6 M
Slightly volatile
Other Assets205.8 M214.2 M260.6 M
Slightly volatile
Long Term Debt3.4 B2.4 B4.8 B
Slightly volatile
Long Term Debt Total3.4 B2.5 B4.8 B
Slightly volatile
Property Plant Equipment552.6 M663.5 M443.1 M
Slightly volatile
Capital Surpluse3.4 B1.9 B5.6 B
Slightly volatile
Cash And Equivalents166.2 M201.2 M136.7 M
Slightly volatile

Galderma Group Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization265.5 M336.9 M239.8 M
Slightly volatile
Interest Expense418 M364.6 M343 M
Slightly volatile
Selling General Administrative495.8 M624.5 M400.8 M
Slightly volatile
Selling And Marketing Expenses1.5 B1.7 B1.3 B
Slightly volatile
Total Revenue4.1 B5.1 B3.4 B
Slightly volatile
Gross Profit2.8 B3.5 B2.4 B
Slightly volatile
Other Operating Expenses3.6 B4.4 B3.1 B
Slightly volatile
Operating Income492.4 M741.8 M372.6 M
Slightly volatile
EBIT481.8 M765.9 M336.9 M
Slightly volatile
Research Development226.6 M234 M296.4 M
Slightly volatile
EBITDA747.4 M1.1 B576.7 M
Slightly volatile
Cost Of Revenue1.3 B1.6 B1 B
Slightly volatile
Total Operating Expenses2.3 B2.8 B2 B
Slightly volatile
Income Tax Expense51.5 M90.8 M22.1 M
Slightly volatile
Tax Provision70.4 M90.8 M52.6 M
Slightly volatile
Interest Income339.7 M312.3 M377 M
Very volatile

Galderma Group Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow323 M423.2 M327 M
Very volatile
Depreciation294.9 M336.9 M264 M
Slightly volatile
Capital Expenditures177.8 M316.2 M142.8 M
Slightly volatile
Total Cash From Operating Activities518.9 M494.2 M226.2 M
Slightly volatile
End Period Cash Flow351 M525.5 M316.6 M
Slightly volatile
Stock Based Compensation54.4 M61.2 M66.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.274.854.0475
Very volatile
PTB Ratio3.293.533.0694
Slightly volatile
Days Sales Outstanding76.9786.0376.4411
Pretty Stable
Book Value Per Share17.3329.5219.1413
Slightly volatile
Operating Cash Flow Per Share1.711.630.8953
Slightly volatile
Average Payables408.1 M461.5 M499.6 M
Slightly volatile
Stock Based Compensation To Revenue0.01220.01380.015
Slightly volatile
Capex To Depreciation0.470.840.5151
Slightly volatile
PB Ratio3.293.533.0694
Slightly volatile
EV To Sales4.185.315.4144
Slightly volatile
Inventory Turnover2.463.032.9807
Pretty Stable
Days Of Inventory On Hand131125122
Very volatile
Payables Turnover1.772.142.0854
Pretty Stable
Sales General And Administrative To Revenue0.0960.110.1139
Very volatile
Research And Ddevelopement To Revenue0.08610.06730.0923
Slightly volatile
Capex To Revenue0.03390.05570.0395
Slightly volatile
Cash Per Share1.141.731.2163
Slightly volatile
POCF Ratio92.1163.9674.418
Slightly volatile
Interest Coverage0.981.831.0583
Slightly volatile
Capex To Operating Cash Flow0.960.740.7268
Slightly volatile
Days Payables Outstanding182177175
Slightly volatile
EV To Operating Cash Flow12270.13101
Very volatile
Intangibles To Total Assets0.890.910.8341
Slightly volatile
Net Debt To EBITDA2.622.768.5811
Slightly volatile
Current Ratio0.771.090.863
Slightly volatile
Receivables Turnover4.284.394.8005
Pretty Stable
Graham Number21.4324.1126.3171
Slightly volatile
Shareholders Equity Per Share17.3329.5219.1413
Slightly volatile
Debt To Equity0.390.411.0788
Slightly volatile
Capex Per Share0.541.040.5717
Slightly volatile
Average Receivables559.2 M629.1 M686.6 M
Slightly volatile
Revenue Per Share12.4816.8213.9029
Slightly volatile
Interest Debt Per Share21.7914.921.808
Slightly volatile
Debt To Assets0.420.250.4216
Slightly volatile
Enterprise Value Over EBITDA32.3431.4334.4748
Slightly volatile
Short Term Coverage Ratios67.6964.4612.5923
Slightly volatile
Operating Cycle208211199
Pretty Stable
Price Book Value Ratio3.293.533.0694
Slightly volatile
Days Of Payables Outstanding182177175
Slightly volatile
Price To Operating Cash Flows Ratio92.1163.9674.418
Slightly volatile
Operating Profit Margin0.0960.130.1035
Slightly volatile
Company Equity Multiplier2.611.862.6093
Slightly volatile
Long Term Debt To Capitalization0.50.290.497
Slightly volatile
Total Debt To Capitalization0.510.30.5162
Slightly volatile
Return On Capital Employed0.03580.05230.0357
Slightly volatile
Debt Equity Ratio0.390.411.0788
Slightly volatile
Ebit Per Revenue0.0960.130.1035
Slightly volatile
Quick Ratio0.580.850.6613
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.031.411.4359
Slightly volatile
Cash Ratio0.160.270.1718
Slightly volatile
Cash Conversion Cycle18.8626.623.0908
Very volatile
Operating Cash Flow Sales Ratio0.04430.08710.0578
Pretty Stable
Days Of Inventory Outstanding131125122
Very volatile
Days Of Sales Outstanding76.9786.0376.4411
Pretty Stable
Cash Flow Coverage Ratios0.150.140.0538
Slightly volatile
Price To Book Ratio3.293.533.0694
Slightly volatile
Fixed Asset Turnover9.88.839.6826
Slightly volatile
Capital Expenditure Coverage Ratio1.031.411.4359
Slightly volatile
Price Cash Flow Ratio92.1163.9674.418
Slightly volatile
Enterprise Value Multiple32.3431.4334.4748
Slightly volatile
Debt Ratio0.420.250.4216
Slightly volatile
Cash Flow To Debt Ratio0.150.140.0538
Slightly volatile
Price Sales Ratio3.274.854.0475
Very volatile
Asset Turnover0.260.320.2863
Slightly volatile
Gross Profit Margin0.550.630.6838
Slightly volatile
Price Fair Value3.293.533.0694
Slightly volatile

Galderma Group Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap19.1 B21.5 B23.5 B
Slightly volatile
Enterprise Value21 B23.6 B25.7 B
Slightly volatile

Galderma Fundamental Market Drivers

Forward Price Earnings42.9185
Cash And Short Term Investments457 M

About Galderma Group Financial Statements

Galderma Group investors use historical fundamental indicators, such as Galderma Group's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Galderma Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.3 M840.1 K
Total Revenue5.1 B4.1 B
Cost Of Revenue1.6 B1.3 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.11  0.10 
Research And Ddevelopement To Revenue 0.07  0.09 
Capex To Revenue 0.06  0.03 
Revenue Per Share 16.82  12.48 
Ebit Per Revenue 0.13  0.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Galderma Stock Analysis

When running Galderma Group's price analysis, check to measure Galderma Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galderma Group is operating at the current time. Most of Galderma Group's value examination focuses on studying past and present price action to predict the probability of Galderma Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galderma Group's price. Additionally, you may evaluate how the addition of Galderma Group to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY